Abbott grows cardiac portfolio with Amplatzer approval for valve leaks

Abbott grows cardiac portfolio with Amplatzer approval for valve leaks

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient from another open-heart surgery.

Abbott’s Amplatzer Paraclose PVL Occluder Approved by FDA

October 29, 2026—Abbott announced it has received FDA approval for the Amplatzer Paraclose paravalvular leak (PVL) occluder. According to the company, the transcatheter Amplatzer Paraclose device, which is specifically designed to treat PVL, has an oblong shape and design features that enable effective closure across diverse PVL anatomies. Abbott stated that FDA approval for the Amplatzer Paraclose PVL occluder was supported by clinical data fro…